Published • loading... • Updated
Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populations
Researchers found semaglutide produced the largest weight loss in a 9-trial review of 595 psychiatric patients, but said larger trials are needed.
Summary by News Medical
2 Articles
2 Articles
Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populations
A network meta-analysis of nine randomized controlled trials found that once-weekly semaglutide showed the largest estimated weight-loss effect among GLP-1 receptor agonists tested in adults with mental illness and obesity or related metabolic risk. The authors cautioned that the findings remain preliminary because the evidence base was small, heterogeneous, and largely indirect.
·Mona Vale, Australia
Read Full Article
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
